Results from a study done in the Netherlands suggest that the experimental immunosuppressant drug FTY720 may help control asthma. In the animal study, researchers found that FTY720 suppresses the allergic response that triggers asthma symptoms. The experimental drug is being developed to control autoimmune disorders like multiple sclerosis and lupus, but researchers hope that the findings lead to the development of new asthma treatments.
Read moreThere have been two studies lately – one three years ago published in the New England Journal of Medicine, and then a second one just out... Read more »
If you have multiple sclerosis, it just might be possible that you’ve also experienced the dreaded IVSM. IVSM = Intravenous Solumedrol,... Read more »
There is no cure for rheumatoid arthritis, this almost goes without saying. However, there are a variety of medications which not only... Read more »
While most patients with Ulcerative Colitis and Crohn's Disease do well with amino-salicylates that are extremely safe such as Asacol and... Read more »
While PML (progressive multifocal leukoencephalopathy) sounds scary, advances are being made in its diagnosis and treatment. The first... Read more »
Transplanted pancreatic precursor cells encapsulated in polytetrafluorethylene (PTFE) are protected from the immune system and able to mature into... Read more »
People who have autoimmune diseases and who take glucocorticoid steroids to suppress their immune system may have a higher chance of developing... Read more »
Immunosuppressant drugs used to treat inflammatory bowel disease (IBD) may leave older patients at higher risk of infections, a new Mayo Clinic study... Read more »
Source: ADAM Encyclopedia
ImmunosuppressionPreventionThere is no known way to prevent congenital immunodeficiency disorders. Genetic counseling should be offered to people who... Read more »
Source: ADAM Encyclopedia
Aspergillosis - acute invasive Prevention People who are immunosuppressed because of disease or medications should avoid environments where... Read more »